Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Real-Time Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
RT Nominaldown18.200 -0.460 (-2.465%)
05/02/2020 15:52
{Block Trade}CSPC PHARMA (01093): 1.65m shares, or HK$31.31m
[ET Net News Agency, 5 February 2020] A direct manual trade of 1.65 million shares of CSPC PHARMA (01093) was registered at 3:51p.m. The deal amo ... View All View All

18/11/2019 12:09
CSPC Pharma (01093) 9-month net up 24% to RMB2.81bn
[ET Net News Agency, 18 November 2019] CSPC Pharmaceutical Group Limited (01093) said its profit attributable to owners of the company was RMB2.81 ... View All View All

17/01/2020 10:48
{I-bank focus}Jefferies lifts CSPC Pharma (01093) to HK$22.5
[ET Net News Agency, 17 January 2020] Jefferies Research lifted its target price for CSPC Pharmaceutical (01093) to HK$22.5 from HK$19.7 and mainta ... View All View All

26/02/2020 14:25
CSPC Pharma (01093) gets drug registration approval
[ET Net News Agency, 26 February 2020] CSPC Pharmaceutical Group Limited (01093) said the "Montelukast Sodium Tablets (10mg)" and "Montelukast Sod ... View All View All

Remark: Real time quote last updated: 26/02/2020 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2020 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.